Breast cancer is a condition characterized by an uncontrolled multiplication of breast cells that form a lump, which may be malignant or non-malignant in nature. Such cells usually form tumors that can often be observed on an x-ray or felt as a lump. Breast cancer occurs most commonly among women aged 40 years and above along with a small percentage of men affected by the same. A novel technique of radio occult lesion localization is currently used for detection of non-palpable suspicious breast lesion, which is one of the latest techniques that is expected to gain major traction and in turn fuel growth of the global breast lesion localization methods market over the forecast period (2016–2024). Breast screening programs are favoring early detection of breast cancer, which is further supporting their appropriate treatment with novel techniques. According to Department of Oncology, part of Oxford University, in 2007, around 25% of the cancers were non-palpable that needed specific treatment such as radio-guided occult lesion localization.
Favorable reimbursement policies favoring growth of the breast lesion localization methods market in developed regions
Favorable reimbursement scenario in several developed countries, especially North America further favors growth in research related to finding novel technique to detect cancer. According to American Cancer Society, one time screening mammogram every 12 months is covered fully under Medicare for all women aged 40 and older. Also, it pays for clinical breast exam (CBE) in every 24 months once, for women with average risk of breast cancer. This in turn is expected to increase in rate of breast cancer screening with subsequent increase in growth for breast lesion localization methods market in the near future.
Mammography is one of the most widely used screening technology to identify breast lumps and particularly breast cancer among middle aged women (44 to 65 years age group).
- Mammography units are capable enough to detect lumps in low dense breast tissues
- The devices are gaining acceptance in emerging economies as well. Countries such as India and China have recently witnessed rapid increase in number of installed mammography units.
- This is primarily attributed to higher medical spending on high volume devices along with improving healthcare infrastructure. Installation of mammography units in emerging economies is expected to spur growth of the breast lesion localization methods market
The global breast lesion localization methods market was valued at US$ 400.9 million in 2015 and is expected to witness a robust CAGR of 11.0% during the forecast period (2016 – 2024).
Get The Holistic SAMPLE With Research Methodology:
Figure 1. Global Breast Lesion Localization Methods Market Size and Forecast, US$ Million and Y-o-Y Growth (%), 2014–2024
Source: Coherent Market Insights Analysis (2016)
Rising prevalence and increasing awareness about breast cancer is expected to be one of the primary factor for the growth of breast lesion localization methods market over the period
According to W.H.O, in 2012, breast cancer was the second-most prevalent cancer in the world and most frequent cancer among women, with an estimated around 1.7 Mn new cancer cases diagnosed in 2012. It is the most common cancer in women both in developed and emerging regions. Incidence rates are differ according to region, for instance, the incidence rate in Middle Africa 27 per 100,000 and 92 in Northern America. Furthermore, according to W.H.O, in 2012, breast cancer was the fifth prominent cause for mortality from cancer worldwide. In emerging economies, it is the second highest cause of cancer deaths. In developed regions, it led to around 198,000 deaths in 2012, accounting for 15.4% of all deaths related to cancer. This inadvertently is expected to favor growth of the breast lesion localization methods market in the near future. Furthermore, there has been study that a man also has a risk of developing a breast cancer in their whole life time, although the chances of the situation is mere 1 in 1,000, whereas in female it is around one in every eight women is susceptible for the growth of any type lesion. According to Breastcancer.org, in 2017, in the U.S. around 250,000 cases of invasive breast cancer are expected to be diagnosed along with over 60,000 cases of non-invasive breast cancer. This in turn creates a highly conducive environment for global breast lesion localization methods market in the near future.
Large potential in untapped emerging economies is expected to fuel the growth in breast lesion localization methods market
Continuous rise in population in emerging economies such as India and increasing focus towards strengthening of the healthcare infrastructure in the region are expected to provide major growth traction for the breast lesion localization methods market in the near future. Furthermore, according to The Pink Initiative and Breast Cancer Statistics in India, in 2014, a significantly large population of patients below the age of 50 years suffered from breast cancer. The exact statistics represents that around 16% were in the age between 20 and 40 and 28% were in age between 40 and 50. Increasing awareness in such regions with high potential is expected to improve the time to market of highly effective and advanced products. The breast lesion localization methods market is expected to surge on a wave of renewed interest by healthcare providers and governments alike to tackle the menace of breast cancer in the not-so distant future.
Get Table Of Content: